期刊文献+

阿托伐他汀调脂联合降压药物对老年高血压患者降压平稳性的研究 被引量:7

Study of atorvastatin combined antihypertensive drugs in blood pressure stationarity in elderly patients with hypertension
在线阅读 下载PDF
导出
摘要 目的观察老年高血压患者应用阿托伐他汀调脂联合贝那普利和氨氯地平降压的平稳性。方法 180例高血压患者(2~3级)随机分配到单纯降压组和调脂联合降压组,治疗前进行血脂及24h动态血压监测,所有高血压患者接受贝那普利和氨氯地平联合治疗2~4周,治疗后诊室血压达标后(<140/90mmHg)入组,调脂联合降压组加用阿托伐他汀(10mg,口服,1次/d),3月后2组分别进行血脂及24h动态血压监测;记录24h平均收缩压(24hSBP)及24h平均舒张压(24hDBP),计算24h收缩、舒张压平滑指数(SISBP和SIDBP)及脉压(PP)、脉压指数(PPI),分别比较2组病人治疗前后血脂、动态血压值及其稳定性的变化。结果 3月后,2组患者血压控制良好,与治疗前比较,调脂降压组患者:总胆固醇[(5.75±0.4)mmol/L比(3.77±0.15)mmol/L]、三酰甘油[(1.85±0.27)mmol/L比(1.23±0.10)mmol/L]水平明显降低(P<0.01);与单纯降压组相比,PP[(47±6)mmHg比(53±8)mmHg]及PPI[(0.36±0.08)mmHg比(0.40±0.06)mmHg]明显降低(P<0.05),而SISBP[(1.52±0.16)mmol/L比(1.40±0.15)mmol/L]和SIDBP[(1.37±0.13)mmol/L比(1.28±0.11)mmol/L]明显升高(P<0.05或P<0.01)。结论阿托伐他汀降脂联合降压治疗能更有效降低≥2级高血压患者动态血压的PP及PPI,并且明显提高血压平滑指数. Objective To observe the effect of atorvastatin combined with benazepril and amlodipinethe in stability of blood pressure in elderly hypertensive patients. Methods 180 patients with grade 2 or 3 hypertension were randomly assigned to the simple depressurization group and combination group(lowering-lipid combined with depressurization). Blood lipids and 24 h ambulatory blood pressure were measured before treatment. All hypertensive patients received benazepril and amlodipine combination therapy until the blood pressure reached the standard, and the combination group received atorvastatin (10 mg,take orally,1time/d)additionaly. Blood lipids and 24 h ambulatory blood pressure were measured after 3 months. The smoothness index(SI) of 24 h systolic and diastolic blood pressure (SISBP and SIDBP), pulse pressure (PP)and pulse pressure index (PPI) were recorded. Blood lipids, ambulatory blood pressure values and their stability were respectively compared between the two groups of patients before and after treatment. Results After 3 months, blood pressure control in two groups is good.After 3 months,the levels of total cholesterol (5.75±0.4 mmol/L vs 3.77±0.15 mmol/L) and triglycerides (1.85±0.27 mmol/L vs 1.23±0.10 mmol/L) in combination group were decreased significantly than those before treatment(P<0.01); Compared with simple depressurization group, PP (47±6 mmHg vs 53±8 mmHg) and PPI (0.36±0.08 mmHg vs 0.40±0.06 mmHg)in combination group were significantly lower (P<0.05), while SISBP (1.52±0.16 mmol/L vs 1.40±0.15 mmol/L) and SIDBP (1.37±0.13 mmol/L vs 1.28±0.11 mmol/L) were significantly higher (P<0.05 or P< 0.01). Conclusions Atorvastatin combined antihypertensive therapy can more effectively reduce PP and PPI in patients with grade 2 or 3 hypertension, and significantly increase SI of blood pressure.
出处 《实用老年医学》 CAS 2013年第6期508-510,共3页 Practical Geriatrics
基金 上海市嘉定区卫生局青年基金课题(QWKYJJ)
关键词 阿托伐他汀 联合降压 平滑指数 老年人 atorvastatin combining antihypertension smoothness index aged
  • 相关文献

参考文献7

  • 1盛骏骎,蒋世峰,毛旭东.阿托伐他汀钙对慢性心力衰竭患者血浆内皮素及心功能的影响[J].实用老年医学,2011,25(4):314-316. 被引量:20
  • 2胡大一,王宏宇.亚临床血管病变与临床实践(下)[J].中国医刊,2003,38(1):52-54. 被引量:17
  • 3胡大一,王宏宇.亚临床血管病变与临床实践(上)[J].中国医刊,2002,37(12):40-42. 被引量:24
  • 4Parati G,Omboni S,Rizzoni D,et al.The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension[].Journal of Hypertension.1998
  • 5Kjeldsen SE,Jamerson KA,Bakfis GL,et al.Predictors of blood pressure response to inten-sified and fixed combination treatment of hy-pertension:the ACCOMPLISH study[].Blood Pressure.2008
  • 6Eiichiro Yamamoto,Takuro Yamashita,Tomoko Tanaka, et al.Pravastatin Enhances Beneficial Effects of Olmesartan on Vascular Injury of Salt-Sensitive Hypertensive Rats, via Pleiotropic Effects[].Arterioscler Thromb Vasc Biol.2007
  • 7Li Y,Wang JG,Staessen JA,et al.Ambulatory arterial stiffness index derived from24-hour ambulatory blood pres-sure monitoring[].Journal of Hypertension.2006

二级参考文献24

  • 1[1]Benetos A.Pulse pressure and cardiovascular risk. J Hypertees, 1999, 17(Suppl 5) :S21 -S24
  • 2[2]Guidelines subcommittee. 1999 world health organization/international society of hypertension guidelines for the management of hypertension . J Hypertens, 1999,17:151 - 183
  • 3[3]Alderman MH. A new model of risk: implications of increasing pulse pressure and systolic blood pressure on cardiovascular disease. J Hypertens, 1999,17(Suppl 5) :S25 - 28
  • 4[7]Vaccarino V, Holford TR, Krumholz HM. pulse pressure and risk for myocardial infarction and heart failure in the elderly. J Am Coll Cardiol.2000;36:130 - 138.
  • 5[8]Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation, 2001,103:1245 - 1249
  • 6[9]Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patientis. A longitudinal study. Hypertension,2002,39:10 - 15
  • 7[13]Wang Hy, Hu DY, Sun NL, et al. Effect of long - acting isosorbide - 5mononitrate administration on large artery distensibility in patients with essential hypertension. Hypertens Res, 2001,24: 311 - 314
  • 8Giannessi D, Del Ry S, Vitale RL. The role of endothe]ins and their receptors in heart failure [ J ]. Pharmacol Res, 2001,43 (2) :111-126.
  • 9Piepho RW. Overview of the angiotensin-converting-enzymeinhibitors[ J ]. Am J Health Syst Pharm, 2000,57 ( Suppl 1 ) : S3-S7.
  • 10Eryonucu B, KoldasL, Ayan F, et al. Comparison of the first dose response of fosinopril and captopril in congestive heart failure : a randomized, double-blind, placebo controlled study [ J]. Jpn Heart J,2001,42(2) : 185-191.

共引文献48

同被引文献58

  • 1杨敏,范茂丹,周磊.老年高血压患者降压药物的应用及用药指导[J].中国疗养医学,2011,20(8):749-750. 被引量:9
  • 2张文斌,宋筱筱,傅国胜,蔡思宇.他汀类药物临床研究进展[J].心血管病学进展,2006,27(1):79-82. 被引量:40
  • 3胡大一 马长生.心脏病学实践[M].北京:人民卫生出版社,2003.23-31.
  • 4Willarms B.Angiotensin Ⅱand the pathophysiology of cardio-vascular remodeling[J].Am J Cardiol,2001,87(8A):10-17.
  • 5Jouniden Rs,Haegoneli WE,Linder L,et al.Nitric aidere-sponsiblc for flow-dependent dilation of peripheral conduuilarteiesnvivo[J].Circulation,1998,19(2):1311-1339.
  • 6Honffer SM.Epidemiolgy of hypertension and insulin resis-tancesyndrome[J].Hypertesion,1997,15(1):25-30.
  • 7林玉荣.盐酸贝那普利对高血压病病人胰岛素抵抗的影响[J].中华中西医杂志,2006,7(6):19-21.
  • 8Kanbay M, Yildirir A, Bozbas H, et al. Stat in therapy helps to control blood pressure levels in hypertensive dyslipidemic patients[J]. Ren Fail,2005,27(3) :297-303.
  • 9Lee TM, Lin MS, Tsai CH, et al. Add-on and withdrawal effect of pravastatin on proteinuria in hypertensive patients treated withAT receptor bloekers[J]. Kidney Int,2005,68(2): 779-787.
  • 10Yamamoto E, Yamashita T, Tanaka T, et al. Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt sensitive hypertensive rats, via pleiotropic effects[J].Arterioseler Thromb Vasc Biol,2007,27(3): 556-558.

引证文献7

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部